SCHEMBL24003919

SCHEMBL24003919

Cc1cc(Nc2cccc(NC(=O)c3ccc(Nc4ccncc4)cc3)c2)cc(N)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ KCNK3 O14649 2/20 0.52
▸ KCNK9 Q9NPC2 1/20 0.52
▸ DNMT1 P26358 3/20 0.51
▸ DNMT3A Q9Y6K1 3/20 0.51
▸ DNMT3L Q9UJW3 2/20 0.51
▸ CCNT1 O60563 1/20 0.47
▸ CCNE1 P24864 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ CDK9 P50750 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ NT5E P21589 1/20 0.46
▸ NAMPT P43490 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MITF O75030 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ ABL1 P00519 3/20 0.45
▸ BCR P11274 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24006110 1.00 POLB (0.55) POLBMAPTKCNK3KCNK9DNMT1
SCHEMBL30287677 1.00 POLB (0.55) POLBMAPTKCNK3KCNK9DNMT1
SCHEMBL30232750 1.00 POLB (0.55) POLBMAPTKCNK3KCNK9DNMT1
SCHEMBL26328429 0.92 KCNK3 (0.57) POLBMAPTKCNK3KCNK9DNMT1
SCHEMBL26321817 0.89 ABL1 (0.51) POLBMAPTKCNK3KCNK9DNMT1
SCHEMBL26315464 0.86 KCNK3 (0.51) POLBMAPTKCNK3KCNK9DNMT1
SCHEMBL30290811 0.85 KCNK3 (0.53) POLBKCNK3KCNK9DNMT1DNMT3A
SCHEMBL24010669 0.85 KCNK3 (0.53) POLBKCNK3KCNK9DNMT1DNMT3A
SCHEMBL24006101 0.85 POLB (0.61) POLBMAPTKCNK3KCNK9DNMT1
SCHEMBL30232732 0.85 KCNK3 (0.57) POLBMAPTKCNK3KCNK9DNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 — — WO disclosed
CN-115996939-A AKT3 modulators 乔治穆内有限责任公司 2023-04-21 — — CN disclosed
WO-2021226517-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR POLB 2552/4885MAPT 3962/4885KCNK3 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback